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Abstract
Background: Neurosteroids have various physiological and neuropsychopharmacological effects. In addition to the
genomic effects of steroids, some neurosteroids modulate several neurotransmitter receptors and channels, such as N-
methyl-D-aspartate receptors, c-aminobutyric acid type A (GABAA) receptors, and s1 receptors, and voltage-gated Ca
2+ and
K
+ channels. However, the molecular mechanisms underlying the various effects of neurosteroids have not yet been
sufficiently clarified. In the nervous system, inwardly rectifying K
+ (Kir) channels also play important roles in the control of
resting membrane potential, cellular excitability and K
+ homeostasis. Among constitutively active Kir2 channels in a major
Kir subfamily, Kir2.3 channels are expressed predominantly in the forebrain, a brain area related to cognition, memory,
emotion, and neuropsychiatric disorders.
Methodology/Principal Findings: The present study examined the effects of various neurosteroids on Kir2.3 channels using
the Xenopus oocyte expression assay. In oocytes injected with Kir2.3 mRNA, only pregnenolone sulfate (PREGS), among nine
neurosteroids tested, reversibly potentiated Kir2.3 currents. The potentiation effect was concentration-dependent in the
micromolar range, and the current-voltage relationship showed inward rectification. However, the potentiation effect of
PREGS was not observed when PREGS was applied intracellularly and was not affected by extracellular pH conditions.
Furthermore, although Kir1.1, Kir2.1, Kir2.2, and Kir3 channels were insensitive to PREGS, in oocytes injected with Kir2.1/
Kir2.3 or Kir2.2/Kir2.3 mRNA, but not Kir2.1/Kir2.2 mRNA, PREGS potentiated Kir currents. These potentiation properties in
the concentration-response relationships were less potent than for Kir2.3 channels, suggesting action of PREGS on Kir2.3-
containing Kir2 heteromeric channels.
Conclusions/Significance: The present results suggest that PREGS acts as a positive modulator of Kir2.3 channels. Kir2.3
channel potentiation may provide novel insights into the various effects of PREGS.
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Introduction
Neurosteroids are synthesized by neurons and glial cells in the
central and peripheralnervous system from cholesterol orother blood-
borne steroidal precursors [1,2]. In addition to the genomic effects of
steroids via intracellular steroid receptors, some steroids modulate the
functions of several neurotransmitter receptors and channels, namely
c-aminobutyric acid typeA (GABAA) receptors,N-methyl-D-aspartate
(NMDA) receptors, serotonin (5-hydroxytryptamine, 5-HT) subtype 3
(5-HT3) receptors, and s1 receptors [3], voltage-gated Ca
2+ and K
+
channels [4,5], and transient receptor potential M3 channels [6],
possibly leading to modulation of neuronal excitability. Steroids with
these properties are referred to as neuroactive steroids independently
of their origin [3]. Neurosteroids have been shown to have a variety of
neuropsychopharmacological effects, such as neuroprotective, mem-
ory-enhancing, sedative, anxiolytic, sleep-modulating, antidepressant,
anticonvulsant and anesthetic effects [2,3]. However, the molecular
mechanisms underlying the various effects of neurosteroids have not
yet been sufficiently clarified.
Inwardly rectifying K
+ (Kir) channels play important roles in the
control of resting membrane potential, cellular excitability and K
+
homeostasis in the nervous system and various peripheral tissues [7].
Among seven Kir subfamilies, members of Kir2 channels in a major
Kir subfamily are characterized by strong inward rectification and
constitutive activity and are present in various cells, including neurons,
glial cells, cardiac and skeletal myocytes, epithelial cells, and
macrophages [8]. Four Kir2 channel members have been identified
in mammals [9–13]. In the nervous system, Kir2.1 channels are
expressed widely but weakly in most brain regions. Kir2.2 channels
are expressed mainly in the cerebellum. Kir2.3 channels are expressed
predominantly in the forebrain [14,15]. Kir2.4 channels are expressed
predominantly in motoneurons of the brainstem [13]. Among Kir2
channels, Kir2.3 channels in the forebrain may be related to
cognition, memory, emotion and neuropsychiatric disorders. There-
fore, endogenous modulators of Kir2.3 channels may induce various
physiological and neuropsychopharmacological effects. In the present
study, we investigated the effects of various neurosteroids on Kir2.3
channels using the Xenopus oocyte expression assay.
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PREGS potentiates Kir2.3 channels
In Xenopus oocytes injected with Kir2.3 mRNA, inward currents
through the expressed Kir 2.3 channels were observed at a holding
potential of 270 mV in an hK solution containing 96 mM K
+
(Fig. 1A). Extracellular application of 30 mM pregnenolone sulfate
(PREGS) reversibly potentiated Kir2.3 currents (Fig. 1A). The
current responses to an additional 50 mM PREGS during
application of 3 mM Ba
2+, which blocks Kir channels, were not
significant (1.561.0 nA, less than 1% of the 3 mM Ba
2+-sensitive
current component, n=4; Fig. 1A). The 3 mM Ba
2+-sensitive
current components in oocytes expressing Kir2.3 channels
(684.7679.2 nA, n=25) are considered to correspond to the
magnitudes of Kir2.3 currents in oocytes expressing Kir2.3
channels [11]. PREGS produced no significant response in the
K
+-free ND98 solution containing 98 mM Na
+ instead of the hK
solution (5.762.0 nA at 50 mM, n=4), suggesting that the
PREGS-induced currents show K
+ selectivity. In uninjected
oocytes, 300 mM PREGS and 3 mM Ba
2+ produced no significant
response (less than 5 nA and 3.262.5 nA, respectively, n=5;
Fig. 1A) compared with oocytes injected with Kir2.3 mRNA,
suggesting no significant effect of PREGS and Ba
2+ on intrinsic
oocyte channels. Additionally, application of dimethyl sulfoxide
(DMSO), the solvent vehicle, at the highest concentration (0.3%)
produced no significant response in oocytes injected with Kir2.3
mRNA (n=4; data not shown). In contrast, 100 mM of the other
neurosteroids tested: PREG, dehydroepiandrosterone (DHEA),
DHEAS, progesterone, 17b-estradiol, corticosterone, 5a-pregnan-
3a-ol-20-one (3a-OH-DHP, also known as allopregnanolone) and
3a, 21-dihydroxy-5a-pregnan-20-one (also known as tetrahydro-
deoxycorticosterone, THDOC), produced no significant current
responses in oocytes expressing Kir2.3 channels (less than 2%
change of the 3 mM Ba
2+-sensitive current component, with the
exception of DHEAS with only 5.662.6% potentiation, n$4;
Fig. 1B). The results suggest that Kir2.3 channels are potentiated
specifically by PREGS among various neurosteroids.
Characteristics of Kir2.3 channel potentiation by PREGS
The potentiation of Kir2.3 channels by PREGS was concen-
tration-dependent at micromolar concentrations, with a concen-
tration of PREGS that produces 50% of the maximal effect (EC50)
of 15.660.9 mM and a Hill coefficient (nH) of 1.4360.03 (n=6,
Fig. 2A). The amplitudes of 30 mM PREGS-potentiated Kir2.3
currents were highly correlated with those of 3 mM Ba
2+-sensitive
current components (Fig. 2B), suggesting that the effects of
PREGS may be associated with Kir2.3 channel expression levels.
Furthermore,instantaneousKir2.3currents elicitedby thevoltage
step to 2100 mV from a holding potential of 0 mV were enhanced
in the presence of 30 mM PREGS applied for 3.5 min (Fig. 2C). The
percentage potentiation of the steady-state Kir2.3 current at the end
of the voltage step by PREGS was not significantly different from
thatof theinstantaneouscurrent (paired t-test, P.0.05; n=6at240,
260, 280, 2100 and 2120 mV, respectively). These results suggest
that the channels were potentiated by PREGS primarily at the
holdingpotentialof0 mVandinatime-independentmannerduring
each voltage pulse. Similarly to 3 mM Ba
2+-sensitive currents
corresponding to Kir2.3 currents, PREGS-induced currents in
oocytes expressing Kir2.3 channels increased with negative
membrane potentials, and the current-voltage relationships showed
inward rectification (Fig. 2D), indicating a characteristic of Kir
currents. Furthermore, the PREGS-induced current did not change
the reversal potential. These results suggest that PREGS potentiates
the function of Kir2.3 channels.
The effects of intracellular PREGS in oocytes expressing Kir2.3
channels were also examined. The 3 mM Ba
2+-sensitive current
components corresponding to the magnitudes of Kir2.3 currents
were not significantly affected by intracellularly applied PREGS
(88.4612.1% of untreated control, P.0.05, paired t-test, n=4;
Fig. 3A), and extracellular application of 50 mM PREGS after the
injection similarly potentiated Kir currents (P.0.05, paired t-test,
n=4; Fig. 3B). These results suggest that the potentiation effect of
PREGS was not caused by its intracellular action.
The chemical structure of PREGS shares the structural moiety of
PREG and DHEAS [3]. However, 30 mM PREGS-induced Kir2.3
currents were not significantly different from those in the presence
of either 100 mM PREG or 100 mM DHEAS (105.9611.4% and
99.868.9% of control, respectively, P.0.05, n=4, paired t-test;
Fig. 4), suggesting that PREG and DHEAS have no significant
antagonist effect on the potentiation of Kir2.3 channels by PREGS.
Kir2.3 channels are modulated by extracellular pH [16–18].
We examined whether changes in pH would alter the effects of
Figure 1. Effects of pregnenolone sulfate (PREGS) on Kir2.3
channels expressed in Xenopus oocytes. (A) Upper row, in an
oocyte injected with Kir2.3 mRNA, current responses to 30 mM PREGS
and to 50 mM PREGS in the presence of 3 mM Ba
2+ are shown. Lower
row, in an uninjected oocyte, no significant current responses to
300 mM PREGS and 3 mM Ba
2+ are shown. Current responses were
measured at a membrane potential of 270 mV in an hK solution
containing 96 mM K
+. Asterisks show the zero current level. Horizontal
bars show the duration of application. (B) Effects of various
neurosteroids: PREG, PREGS, DHEA, DHEAS, progesterone (PROG),
17b-estradiol (E2), corticosterone (CORT), 3a-OH-DHP and THDOC, on
Kir2.3 channels. The magnitudes of the effect of 100 mM neurosteroids
on Kir2.3 channels were normalized to the 3 mM Ba
2+-sensitive current
components in oocytes expressing Kir2.3 channels (n$4 for each
steroid). Data are expressed as mean6SEM.
doi:10.1371/journal.pone.0006311.g001
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oocytes injected with Kir2.3 mRNA, Kir2.3 currents decreased
with a decrease in extracellular pH (51.967.9% of the 3 mM
Ba
2+-sensitive current components at pH 7.4 for pH 6.0, n=6;
and 167.6622.1% of those at pH 7.4 for pH 9.0, n=6) as
reported in previous studies [16–18]. However, the concentration-
response relationships for the potentiation effects of PREGS were
not significantly affected by pH 6.0, 7.4 and 9.0 (no significant pH
6 PREGS interaction, P.0.05, two-way ANOVA; P.0.05 at
each concentration, Tukey-Kramer post hoc test; Fig. 5). These
results suggest that the degree of potentiation of Kir2.3 channels
by PREGS may be similar even under pathological pH conditions.
Selective potentiation of Kir2.3 channels by PREGS
We also examined the effects of PREGS on other Kir channels
(i.e., Kir1.1, an ATP-regulated Kir channel; Kir2.1 and Kir2.2,
constitutively active Kir channels; Kir3, a G protein-activated Kir
channel [7]). However, in oocytes injected with mRNA for Kir1.1,
Kir2.1, Kir2.2, or Kir3.1/Kir3.2 channels, 100 mM PREGS
produced no significant current response (3.560.4, 7.263.7,
4.062.5,and 0.861.6% change of the 3 mM Ba
2+-sensitive current
components: 820.76190.8 nA for Kir1.1, 538.06130.9 nA for
Kir2.1, 1518.36276.4 nA for Kir2.2, and 1043.56166.0 nA for
Kir3.1/Kir3.2, respectively, n$4; Fig. 6). These results suggest that
PREGS selectively potentiates Kir2.3 channels.
Figure 2. Characteristics of Kir2.3 channel potentiation by PREGS. (A) Concentration-dependent effect of PREGS on Kir2.3 channels. The
magnitudes of Kir2.3 currents potentiated by PREGS were normalized to the 3 mM Ba
2+-sensitive current components in Xenopus oocytes expressing
Kir2.3 channels (554.0679.9 nA, n=6). Data are expressed as mean6SEM of the percentage responses. (B) Correlation between amplitudes of current
response to 30 mM PREGS and amplitudes of the 3 mM Ba
2+-sensitive current components in oocytes expressing Kir2.3 channels. The correlation
coefficient was 0.894 (P,0.05, n=22, regression analysis). Current responses were measured at a membrane potential of 270 mV in an hK solution
containing 96 mM K
+. (C) Representative Kir2.3 currents elicited by a voltage step to 2100 mV for 2 s from a holding potential of 0 mV in the
presence or absence of 30 mM PREGS in an oocyte injected with Kir2.3 mRNA. Arrow indicates the zero current level. (D) Current-voltage relationships
of 3 mM Ba
2+-sensitive currents and 30 mM PREGS-enhanced currents in oocytes expressing Kir2.3 channels. Current responses were normalized to
the 3 mM Ba
2+-sensitive current component measured at a membrane potential of 2100 mV (1510.06209.9 nA, n=6).
doi:10.1371/journal.pone.0006311.g002
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Recent studies have shown that Kir2 channel subunits can form
functional heteromeric channels in the Xenopus oocyte expression
system [19,20]. We examined the effects of PREGS on Kir2
heteromeric channels. In oocytes injected with mRNA for Kir2.1/
Kir2.3 or Kir2.2/Kir2.3, PREGS concentration-dependently
potentiated Kir currents (respective EC50 and nH: 41.069.4 mM
and 1.4060.23 for Kir2.1/Kir2.3, n=6; 27.565.0 mM and
1.0760.07 for Kir2.2/Kir2.3, n=9; Fig. 7), whereas PREGS
had no significant current response in oocytes injected with
Kir2.1/Kir2.2 mRNA (1.361.3% inhibition of the 3 mM Ba
2+-
sensitive current components, n=5). The potentiation properties
of PREGS in the normalized concentration-response relationships
were less potent for Kir2.1/Kir2.3 and Kir2.2/Kir2.3 than for
Kir2.3 channels (EC50: P,0.05, one-way ANOVA; significant
difference between Kir2.1/Kir2.3 and Kir2.3, P,0.05, Tukey-
Kramer post hoc test; and significant channel-type 6 PREGS
Figure 3. Effect of intracellular PREGS in Xenopus oocytes expressing Kir2.3 channels. (A) Comparison of basal Kir2.3 currents before and
after PREGS injection in oocytes expressing Kir2.3 channels. The amplitude of Kir2.3 currents was normalized to the amplitude of 3 mM Ba
2+-sensitive
current components before PREGS injection. (B) Comparison of 50 mM PREGS-induced Kir2.3 currents before and after PREGS injection. Data are
expressed as mean6SEM.
doi:10.1371/journal.pone.0006311.g003
Figure 4. Effects of PREG and DHEAS on PREGS-induced Kir2.3
currents. (A) Representative current responses to 30 mM PREGS and to
30 mM PREGS in the presence of 100 mM PREG in a Xenopus oocyte
expressing Kir2.3 channels. Current responses were measured at a
membrane potential of 270 mV in an hK solution containing 96 mM
K
+. (B) Comparison of PREGS-induced Kir2.3 currents in the presence or
absence of PREG or DHEAS. Concentrations of PREGS, PREG, and DHEAS
were 30, 100, and 100 mM, respectively. Current responses to PREGS in
the presence of PREG or DHEAS were normalized to the amplitude of
PREGS-induced currents in the absence of PREG or DHEAS (control).
Data are expressed as mean6SEM.
doi:10.1371/journal.pone.0006311.g004
Figure 5. Concentration-response relationships for potentia-
tion of Kir2.3 channels by PREGS at different pH values. The
magnitudes of potentiation of Kir2.3 currents by PREGS in oocytes
expressing Kir2.3 channels were normalized to the 3 mM Ba
2+-sensitive
current components, which were 426.9.6641.4 nA (pH 6.0),
554.0679.9 nA (pH 7.4) and 729.2636.6 nA (pH 9.0). The EC50 and nH
values were 16.161.2 mM and 1.4460.07 (pH 6.0, n=10), 15.660.9 mM
and 1.4360.03 (pH 7.4, n=6), and 17.161.5 mM and 0.7060.03 (pH 9.0,
n=8), respectively. Current responses were measured at a membrane
potential of 270 mV in an hK solution containing 96 mM K
+. Data are
expressed as mean6SEM of the percentage responses.
doi:10.1371/journal.pone.0006311.g005
PREGS Potentiates Kir2.3
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Tukey-Kramer post hoc test). The results suggest that PREGS
may also potentiate Kir2.3-containing Kir2 heteromeric channels.
Discussion
In the present study, we demonstrated that PREGS potentiated
the function of Kir2.3 channels at micromolar concentrations,
whereas the eight other neurosteroids (i.e., PREG, DHEA,
DHEAS, progesterone, 17b-estradiol, corticosterone, 3a-OH-
DHP, and THDOC) had no significant effect on Kir2.3 channels.
Kir1.1, Kir2.1, Kir2.2 and Kir3 channels in other members of the
Kir channel family were insensitive to PREGS. These results
suggest that the endogenous steroid PREGS may selectively act as
a positive modulator of Kir2.3 channels. Furthermore, the effect of
PREGS on Kir2.3 channels was not caused by intracellularly
applied PREGS, and potentiation of Kir2.3 channels by
extracellularly applied PREGS was readily reversible with
washout. PREGS exists in a negatively charged form, and it
could not readily permeate the cell membrane. Therefore, the
effect of PREGS was unlikely to be caused by intracellular PREGS
or by interactions with intracellular molecules, including phos-
phatidylinositol 4,5-bisphosphate (PIP2) and long-chain fatty acids
that activate Kir2.3 channels [21,22]. Additionally, PREG and
DHEAS, whose structures are closely related to PREGS, had no
significant effects on Kir2.3 channels or on PREGS-induced
Kir2.3 potentiation, suggesting that the effect of PREGS is unlikely
to be mediated by a nonspecific membrane-perturbation effect.
These observations suggest that PREGS may act directly at Kir2.3
channels, and the site of action of PREGS on Kir2.3 channels may
be extracellular or, at least, at a readily accessible site from the
outside of the cell membrane. Moreover, the present study
suggests that PREGS also potentiates Kir2 heteromeric channels
containing Kir2.3 channel subunits. The Kir2.3 channel may be
considered as a target site for PREGS.
Administration of PREGS has been shown to have antiamnesic,
anxiolytic, antidepressant, neurogenesis, neuroprotective, procon-
vulsant, and antinociceptive effects [23–29] and prevent the
development of tolerance and dependence to morphine and
benzodiazepines [30,31]. PREGS at micromolar concentrations
has also been shown to modulate the functions of several receptors
and channels, namely GABAA receptors, glycine receptors, NMDA
receptors, a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
(AMPA) receptors, s1 receptors, voltage-gated Ca
2+ and K
+
channels, and transient receptor potential M3 channels [3–6,27].
PREGS can cross the blood-brain barrier [32], and interactions of
PREGS with these target sites are proposed to have important
implications in the various effects of PREGS. Kir2.3 channels are
highly expressed in neurons and some of oligodendroglial cells in the
forebrain, such as the olfactory bulb, cerebral cortex, hippocampus
and basal ganglia, and spinal cord [14,15,33,34], areas related to
cognition, memory, emotion, nociception and drug addiction.
Additionally, Kir2.3 channels colocalize with postsynaptic density-
95 (PSD-95) in neuronal populations in the forebrain [35] and are
localized at the postsynaptic membrane of excitatory synapses in the
olfactory bulb [15], suggesting the existence of postsynaptic Kir2.3
channels. In the present study, PREGS potentiated Kir2.3 channels
at micromolar concentrations. Because activation of Kir2.3channels
causes membrane hyperpolarization [36], PREGS may decrease
excitability of neurons and glial cells in these regions. Furthermore,
the distribution of Kir2.1, Kir2.2 and Kir2.3 subunits overlaps in
some regions [14,33,34], suggesting the partial existence of Kir2
heteromeric channels. The present study suggests that PREGS also
potentiates Kir2.3-containing Kir2 heteromeric channels. There-
fore, Kir2.3 potentiation by PREGS might be involved in some of
the various neuropsychopharmacological effects.
Bulk concentrations of PREGS in brain tissues have been estimated
to be in the nanomolar range [37,38], or even lower [39,40].
However, the PREG synthase cytochrome P450 side-chain cleavage
enzyme and hydroxysteroid sulfotransferase, which converts PREG to
PREGS, are expressed in the brain [2], and these enzymes have been
shown to colocalize in hippocampal neurons [38], suggesting local
synthesis of PREGS. Furthermore, Mameli et al. [41] reported that a
PREGS-like neurosteroid released from depolarized postsynaptic
CA1 neurons increased the frequency of AMPA-mediated miniature
excitatorypostsynapticcurrentsvia modulationof presynaptic NMDA
receptors, with a magnitude equivalent to that caused by exogenously
applied PREGS at 17 mM. This effect was blocked by anti-PREGS
antibodies. These findings suggest that local concentrations of released
PREGS around these neurons might be in the micromolar range.
Figure 6. Comparison of the effects of PREGS on Kir1.1, Kir2.1,
Kir2.2, Kir2.3, and Kir3 channels expressed in Xenopus oocytes.
The magnitudes of change in Kir currents by 100 mM PREGS were
normalized to the 3 mM Ba
2+-sensitive current components. For Kir3
channels, oocytes expressing brain-type Kir3.1/Kir3.2 channels were used.
Current responses were measured at a membrane potential of 270 mV in
an hK solution containing 96 mM K
+. Data are expressed as mean6SEM.
doi:10.1371/journal.pone.0006311.g006
Figure 7. Comparison of the potentiation effects of PREGS on
Kir2.3, Kir2.1/Kir2.3, and Kir2.2/Kir2.3 channels expressed in
Xenopus oocytes. Responses to PREGS at different concentrations were
normalized to the maximal response to PREGS. Current responses were
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shown to be elevated under several pathological conditions, such as
cerebral ischemia, epilepsy, stress, and drug addiction [3,42–46].
Altogether, Kir2.3 channels in the forebrain, including the hippo-
campus, might be potentiated by PREGS via paracrine and autocrine
mechanisms under such conditions. Additionally, although PREG is
structurally related to PREGS, PREG had no significant effect on
Kir2.3 channels (Figs. 1B,4). Steroid sulfatase, which converts PREGS
to PREG, has been identified in various brain regions [47–49].
Conversion between PREGS and PREG by sulfotransferase and
steroid sulfatase might regulate the effect of PREGS on Kir2.3
channels in the brain.
Finally, Kir2.3 channels are also expressed in Schwann cells near
the nodes of Ranvier in sciatic nerves, cardiomyocytes, and renal
cortical collecting duct principal cells [50–52]. Typical plasma
concentrations of PREGS have been reported to be 0.2 to 0.4 mM,
although plasma concentrations of PREGS in some healthy subjects
have been reported to be approximately 1 mM [53]. However,
plasma PREGS levels can reach micromolar levels during
pregnancy and in patients with 21-hydroxylase deficiency [54,55].
Elevated PREGS levels overlapped with the concentrations that
were effective in potentiating Kir2.3 channels in the present study.
Additionally, elevated plasma PREGS levels have been observed in
patients with anxiety-depressive disorder, alcohol addiction, or
hyperthyroidism [56–58]. Kir2.3 channels in the peripheral tissues
may be potentiated by elevated PREGS concentrations in certain
conditions. Potentiation of Kir2.3 channels by PREGS might affect
the regulation of K
+ buffering in peripheral nerves, the control of
cardiomyocyte excitability and K
+ homeostasis in the kidney.
Interestingly, PREGS has been identified in sciatic nerves [59], and
PREG has been identified in Schwann cells [60]. In sciatic nerves,
Kir2.3 channels may also be potentiated by locally released
PREGS. Further studies using local administration of PREGS
and in vitro preparations, such as culture cells and brain slices, may
advance our understanding of the physiological and pharmacolog-
ical effects of PREGS on Kir2.3 channels in the nervous system,
heart, and kidney. Kir2.3 channel potentiation may provide novel
insights into the various effects of PREGS.
Materials and Methods
Compounds
PREG, PREGS, DHEA, DHEAS, progesterone, 17b-estradiol,
corticosterone, 3a-OH-DHP, and THDOC were purchased from
Sigma-Aldrich (St. Louis, MO, USA). PREGS was dissolved in
distilled water or DMSO, and the others were dissolved in DMSO.
The stock solution of each compound was stored at 230uC until
use. Each compound was added to the perfusion solution in
appropriate amounts immediately before the experiments.
Preparation of specific mRNA
Plasmids containing the entire coding sequences for the mouse
Kir2.2 (GenBank accession number: AB035889), Kir2.3, Kir3.1, and
Kir3.2 channel subunits were obtained as described previously [61–
63]. The sequence of amino acids deduced from the nucleotide
sequence of C57BL/6NJcl mouse Kir2.2 in the plasmid pSP35T
revealed seven amino acids substitutions compared with BALB/c
mouse Kir2.2 [12]. However, the substitutions were identical to those
of rat Kir2.2, with the exception of a change from Phe to Leu at
codon 255 [10]. Additionally, cDNAs for rat Kir1.1 in pSPORT and
m o u s eK i r 2 . 1i np c D N A 1w e r eg e n e r o u s l yp r o v i d e db yD r s .S t e v e n
C. Hebert and Lily Y. Jan, respectively [9,64]. The plasmid
pSPKir2.2 was linearized by digestion with SacI, and the others
were digested with the appropriate enzyme as described previously
[9,62–64]. The specific mRNAs were synthesized in vitro using the
mMESSAGE mMACHINE
TM In Vitro Transcription Kit (Ambion,
Austin, TX, USA).
Oocyte electrophysiology
Xenopus laevis oocytes (Stages V and VI) were isolated from adult
female frogs (Copacetic, Soma, Aomori, Japan) that were
anesthetized by immersion in water containing 0.15% tricaine
(Sigma-Aldrich) as described previously [65]. All procedures for
the care and treatment of animals were approved by Niigata
University Institutional Animal Care and Use Committee in
accordance with the National Institutes of Health guidelines.
Oocytes were injected with mRNA for Kir1.1 (1 ng), Kir2.1
(0.5 ng), Kir2.2 (0.5 ng), Kir2.3 (1 ng), Kir2.1/Kir2.2, Kir2.1/
Kir2.3, Kir2.2/Kir2.3 (each 0.5 ng), or Kir3.1/Kir3.2 combina-
tions (each 0.3 ng) for brain-type Kir3 channels. Oocytes were
incubated at 19uC in Barth’s solution after treatment with 0.8 mg/
ml collagenase and manually defolliculated. Whole-cell currents of
the oocytes were recorded from 2 to 7 days after the injection with
a conventional two-electrode voltage clamp [62,66]. The mem-
brane potential was held at 270 mV, unless otherwise specified.
Microelectrodes were filled with 3 M KCl. The oocytes were
placed in a 0.05 ml narrow chamber and superfused continuously
with a high-K
+ (hK) solution (composition in mM: KCl 96, NaCl
2, MgCl2 1, CaCl2 1.5 and HEPES 5, pH 7.4 with KOH) or a K
+-
free high-Na
+ (ND98) solution (composition in mM: NaCl 98,
MgCl2 1, CaCl2 1.5 and HEPES 5, pH 7.4 with NaOH). In the
hK solution, the K
+ equilibrium potential was close to 0 mV, and
the inward K
+ current flow through the Kir channels was observed
at negative holding potentials [9,11,12,62,64]. For examining the
effects of intracellular PREGS, 13.8 nl of 10 mM PREGS
dissolved in distilled water containing 5% DMSO was injected
into an oocyte using a Nanoliter injector (World Precision
Instruments, Sarasota, FL, USA) as described previously [67].
The oocyte currents were then continuously recorded for
approximately 30–40 min. Because the volume of the oocyte
was approximately 1 ml, the intracellular concentration of PREGS
was presumed to be approximately 136 mM. Furthermore,
injection of the same volume of the solvent vehicle had no
significant effect on Kir2.3 currents (n=4). For analysis of
concentration-response relationships, data were fitted to a
standard logistic equation using KaleidaGraph (Synergy Software,
Reading, PA, USA). EC50 and nH values were obtained from the
concentration-response relationships.
Data analyses
Data are expressed as mean6SEM, and n is the number of
oocytes tested. Statistical analysis of differences between groups
was performed using paired t-test, one-way analysis of variance
(ANOVA), or two-way ANOVA followed by Tukey-Kramer post
hoc test. Values of P,0.05 were considered statistically significant.
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